In the rapidly evolving world of immune-driven medicine, Adaptive Biotechnologies Corp stands at the frontier of this scientific revolution. As a pioneering force, the company is leveraging the power of the adaptive immune system to redefine the landscape of disease diagnosis and treatment. Its flagship product, clonoSEQ, authorized by the FDA, is a game-changer in […]